Long-Term Effects of Lipoprotein(a) on Carotid Atherosclerosis in Elderly Japanese

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 59, Issue 1, 2004, Pages 62-67

  Iwamoto, Toshihiko ^a   Fukuda, Sara ^a   Shimizu, Souichirou ^a   Takasaki, Masaru ^a  

^a TOKYO MEDICAL UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPROTEIN A;

AGED; AORTA ATHEROSCLEROSIS; ARTICLE; ASIAN; ATHEROSCLEROTIC PLAQUE; BRAIN; CAROTID ARTERY; CIGARETTE SMOKING; COMPUTER ASSISTED DIAGNOSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; ECHOGRAPHY; ELECTROCARDIOGRAM; FEMALE; HEART MUSCLE ISCHEMIA; HISTOGRAM; HUMAN; JAPAN; LIFE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; PRIORITY JOURNAL; RISK FACTOR;

EID: 0347093158     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: 10.1093/gerona/59.1.m62     Document Type: Article

References (33)

1. Hopkins PN, Williams RR. A survey of 246 suggested coronary risk factors. Atherosclerosis. 1981;40:1-52.
2. Simon DI, Ezratty AM, Loscalzo J. Lipoprotein(a) and atherothrombosis. Curr Opin Cardiol. 1993;9:814-820.
3. White AL, Lanford RE. Biosynthesis and metabolism of lipoprotein(a). Curr Opin Lipid. 1995;6:75-80.
4. Nachman RL, Gavish D, Azrolan N, Clarkson TB. Lipoprotein(a) in diet-induced atherosclerosis in nonhuman primates. Arterioscler Thromb. 1991;11:32-38.
5. Rath M, Neindorf A, Reblin T, Dietel M, Krebber HJ, Beisiegel U. Detection and quantification of lipoprotein(a) in the arterial wall of 107 coronary bypass patients. Arteriosclerosis. 1989;9:579-592.
6. Jürgens G, Taddei-Peters WC, Költringer P, et al. Lipoprotein(a) serum concentration and apolipoprotein(a) phenotype correlate with severity and presence of ischemic cerebrovascular disease. Stroke. 1995;26:1841-1848.
7. Zenker G, Költringer P, Bone G, Niederkorn K, Pfeiffer K, Jürgens G. Lipoprotein(a) as a strong indicator for cerebrovascular disease. Stroke. 1986;17:942-945.
8. Willeit J, Kiechl S, Santer P, Oberhollenzer F, Egger G, Jarosch E, Mair A. Lipoprotein(a) and asymptomatic carotid artery disease. Stroke. 1995;26:1582-1587.
9. Jovicic A, Ivanisevic V, Ivanovic I. Lipoprotein(a) in patients with carotid atherosclerosis and ischemic cerebrovascular disorders. Atherosclerosis. 1993;98:59-65.
10. Schreiner PJ, Morrisett JD, Sharrett R, et al. Lipoprotein(a) as a risk factor for preclinical atherosclerosis. Arterioscler Thromb. 1993;13:826-833.
11. Költringer P, Jürgens G. A dominant role of lipoprotein(a) in the investigation and evaluation of parameters indicating the development of cervical atherosclerosis. Atherosclerosis. 1985;58:187-198.
12. Cambillau M, Simon A, Amar J, et al. Serum Lp(a) as a discriminant marker of early atherosclerotic plaque at three extracoronary sites in hypercholesterolemic men. Arterioscler Thromb. 1992;12:1346-1352.
13. Baldassarre D, Tremoli E, Franceschini G, Michelagnoli S, Sirtori CR. Plasma lipoprotein(a) is an independent factor associated with carotid wall thickening in severely but not moderately hypercholesterolemic patients. Stroke. 1996;27:1044-1049.
14. Rhoads GC, Dahlen G, Berg K, Morton NE, Dannenberg AL. Lp(a) lipoprotein as a risk factor for infraction. JAMA. 1986;256:2540-2544.
15. Budde T, Fechtrup C, Bsenberg E, et al. Plasma Lp(a) levels correlate with number, severity, and length-extension of coronary lesions in male patients undergoing coronary arteriography for clinically suspected coronary atherosclerosis. Arterioscler Thromb. 1994;14:1730-1736.
16. Murai A, Miyahara T, Fujimoto N, Matsuda M, Kameyama M. Lp(a) lipoprotein as a risk factor for coronary heart disease and cerebral infarction. Atherosclerosis. 1986;59:199-204.
17. Zhuang Y-Y, Wang J-J, Zu P. Increased lipoprotein(a) as an independent risk factor for cardiovascular and cerebrovascular diseases. Chin Med J. 1993;106:597-600.
18. Jürgens G, Köhringer P. Lipoprotein(a) in ischemic cerebrovascular disease: a new approach to the assessment of risk for stroke. Neurology. 1987;37:513-515.
19. Woo J, Lau E, Lam CWK, et al. Hypertension, lipoprotein(a), and apolipoprotein A-1 as risk factors for stroke in the Chinese. Stroke. 1991;22:203-208.
20. Shitani S, Kikuchi S, Hamaguchi H, Shiigai T. High serum lipoprotein(a) levels are an independent risk factor for cerebral infarction. Stroke. 1993;24:965-969.
21. Milionis HJ, Winder AF, Mikhailidis DP. Lipoprotein(a) and stroke. Clin Pathol. 2000;53:487-496.
22. Ridker PM, Stampfer MJ, Hennekens CH. Plasma concentration of lipoprotein(a) and the risk of future stroke. JAMA. 1995;273:1269-1273.
23. Beletsky VY, Kelley RE, Fowler M, Phifer T. Ultrasound densitometric analysis of carotid plaque composition: pathoanatomic correlation. Stroke. 1996;27:2173-2177.
24. Iwamoto T, Shinozaki K, Kiuchi A, Umahara T, Takasaki, M. Evaluation of B-mode ultrasonographic images of carotid lesions by computer analysis as compared with visual assessment. J Stroke Cerebrovasc Dis. 2003;12:59-65.
25. Howard G, Sharrett AR, Heiss G, et al. Carotid artery intinial-medial thickness distribution in general population as evaluated by B-mode ultrasound. Stroke. 1993;24:1297-1304.
26. Hachinski VC, Steingart A. Leuko-araiosis. Can J Neurol Sci. 1986;13:533-534.
27. Reilly LM, Lusby RJ, Hughes L, Ferrell LD, Stoney RJ, Ehrenfeld WK. Carotid plaque histology using real-time ultrasonography. Am J Surg. 1983;146:188-193.
28. Kagawa R, Moritake K, Shima T, Okada Y. Validity of B-mode ultrasonographic findings in patients undergoing carotid endarterectomy in comparison with angiographic and clinicopathologic features. Stroke. 1996;27:700-705.
29. European Carotid Plaque Study Group. Carotid artery plaque composition: relationship to clinical presentation and ultrasound B-mode imaging. Eur J Vasc Endovascular Surg. 1995;10:23-30.
30. Fuster V, Stein B, Ambrose JA, Badimon L, Badimon JJ, Chesebro JH. Atherosclerotic plaque rupture and thrombosis. Circulation. 1990;82(Suppl II):II47-II59.
31. Glader CA, Boman J, Saikku P, Stenlund H, Weinehall L, Hallmann G, et al. The proatherogenic properties of lipoprotein(a) may be enhanced through the formation of circulating immune complexes containing Chlamydia pneumoniae-specific IgG antibodies. Eur Heart J. 2000;21:639-646.
32. Falk E. Why, do plaques rupture? Circulation. 1992;86(Suppl III): III30-III42.
33. Geroulakos G, Ramaswami G, Nicolaides A, et al. Chracterization of symptomatic and asymptomatic carotid plaques using high-resolution real-time ultrasonography. Br J Surg. 1993;90:1274-1277.